These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29361380)

  • 1. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
    Naseem S; Hussain T; Manzoor S
    Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-27: a double agent in the IL-6 family.
    Jones GW; Hill DG; Cardus A; Jones SA
    Clin Exp Immunol; 2018 Jul; 193(1):37-46. PubMed ID: 29437229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
    Tiegs G
    Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interleukin-20 Cytokine Family in Liver Disease.
    Caparrós E; Francés R
    Front Immunol; 2018; 9():1155. PubMed ID: 29892294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 Rescues Lymphocyte from Apoptosis and Exhaustion Induced by Chronic Hepatitis C Virus Infection.
    Naseem S; Manzoor S; Javed A; Abbas S
    Viral Immunol; 2018 Nov; 31(9):624-631. PubMed ID: 30222516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases.
    Al-Shaebi F; Wenzhang L; Hezam K; Almezgagi M; Wei L
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107023. PubMed ID: 33129098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus.
    Biron CA; Tarrio ML
    Med Microbiol Immunol; 2015 Jun; 204(3):345-54. PubMed ID: 25850988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 pathway in the liver: From physiopathology to therapy.
    Schmidt-Arras D; Rose-John S
    J Hepatol; 2016 Jun; 64(6):1403-15. PubMed ID: 26867490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Toll-like receptors in liver health and disease.
    Broering R; Lu M; Schlaak JF
    Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
    Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
    Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Interleukin-22 in chronic liver injury.
    Carmo RF; Cavalcanti MSM; Moura P
    Cytokine; 2017 Oct; 98():107-114. PubMed ID: 27816383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
    Lott JM; Sumpter TL; Turnquist HR
    J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation.
    Cook SA; Schafer S
    Annu Rev Med; 2020 Jan; 71():263-276. PubMed ID: 31986085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration.
    Drucker C; Gewiese J; Malchow S; Scheller J; Rose-John S
    J Autoimmun; 2010 Feb; 34(1):29-37. PubMed ID: 19717281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
    Rath T; Billmeier U; Waldner MJ; Atreya R; Neurath MF
    Arch Toxicol; 2015 Apr; 89(4):541-54. PubMed ID: 25632846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunobiology of interleukin-27.
    Yoshida H; Hunter CA
    Annu Rev Immunol; 2015; 33():417-43. PubMed ID: 25861977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice.
    Bergmann J; Müller M; Baumann N; Reichert M; Heneweer C; Bolik J; Lücke K; Gruber S; Carambia A; Boretius S; Leuschner I; Becker T; Rabe B; Herkel J; Wunderlich FT; Mittrücker HW; Rose-John S; Schmidt-Arras D
    Hepatology; 2017 Jan; 65(1):89-103. PubMed ID: 27770462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.